Quotient Sciences Conducts Integrated Translational Pharmaceutics® Program in U.S. With Druggability Technologies
3 / 3 events displayed
Event
Join our CEO Mark Egerton at the BVCA Healthcare Forum on February 8, 2019 at The Royal Society, London for his CEO presentation on Quotient Sciences and panel discussion on, "The search for value drivers in pharma: an opportunity of growth for private equity?"
Event
Meet us at DDF in Berlin to discuss to discuss your formulation development, drug product manufacturing or phase I clinical study requirements you may have.
Event
Meet us at CPhI Worldwide in Frankfurt to discuss any formulation development, drug product manufacturing or phase I clinical study requirements you may have.